Literature DB >> 18066479

The ADMIT series - issues in inhalation therapy. 1) The goals of asthma treatment: can they be achieved?

P N Richard Dekhuijzen1, Antoine Magnan, Meinhard Kneussl.   

Abstract

The widespread use of inhaled corticosteroids (ICS) since the early 1970's has meant that asthma is generally better controlled in comparison with previous decades. Nevertheless, recent patient interview surveys indicate that there is still a lot to gain in terms of abolishing daytime and nocturnal symptoms, and asthma exacerbations. It is important to use the terms asthma 'control' and asthma 'severity' in a correct way. Whereas asthma control reflects fluctuation in symptoms and lung function (or lack of them) over time, asthma severity reflects both asthma control and the need for medication. Thus, 'severity' is a property of the disease which reflects the degree of pathophysiological abnormality, whereas 'control' refers to the reduction of the clinical manifestations of disease achieved by treatment - thereby reflecting the adequacy of treatment. This introductory review, the first of a series of review papers to be published in this journal by the ADMIT team (see Appendix), discusses briefly our present knowledge of asthma control, its components, factors that may limit patients' ability to achieve optimal asthma control, and instruments to measure asthma control.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18066479      PMCID: PMC6634251          DOI: 10.3132/pcrj.2007.00081

Source DB:  PubMed          Journal:  Prim Care Respir J        ISSN: 1471-4418


  4 in total

1.  Adequate use of asthma inhalation medication in children: more involvement of the parents seems useful.

Authors:  Johannes H J M Uijen; Yannick J W van Uijthoven; Johannes C van der Wouden; Patrick J E Bindels
Journal:  BMC Res Notes       Date:  2009-07-13

2.  Effectiveness of same versus mixed asthma inhaler devices: a retrospective observational study in primary care.

Authors:  David Price; Henry Chrystyn; Alan Kaplan; John Haughney; Miguel Román-Rodríguez; Annie Burden; Alison Chisholm; Elizabeth V Hillyer; Julie von Ziegenweidt; Muzammil Ali; Thys van der Molen
Journal:  Allergy Asthma Immunol Res       Date:  2012-04-06       Impact factor: 5.764

3.  Qualitative assessment of attributes and ease of use of the ELLIPTA™ dry powder inhaler for delivery of maintenance therapy for asthma and COPD.

Authors:  Henrik Svedsater; Peter Dale; Karl Garrill; Richard Walker; Mark W Woepse
Journal:  BMC Pulm Med       Date:  2013-12-07       Impact factor: 3.317

4.  Adaptation of a difficult-to-manage asthma programme for implementation in the Dutch context: a modified e-Delphi.

Authors:  Persijn J Honkoop; Hilary Pinnock; Regien M M Kievits-Smeets; Peter J Sterk; P N Richard Dekhuijzen; Johannes C C M In 't Veen
Journal:  NPJ Prim Care Respir Med       Date:  2017-02-09       Impact factor: 2.871

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.